An Anti-inflammatory lactobacillus acidophilus composition for regulating immune responses
The combination of live-bacteria and postbiotic powders of Lactobacillus acidophilus, Lactobacillus plantarum, and Bifidobacterium longum addresses the limitations of existing probiotics by enhancing strain synergy and stability, achieving comprehensive immune regulation and intestinal barrier repair.
Patent Information
- Application Number
- PCT/IB2026/053900
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-04-20
- Publication Date
- 2026-06-18
AI Technical Summary
Existing probiotic preparations for anti-inflammatory and immune-regulating purposes suffer from insufficient strain synergy, poor environmental tolerance of live bacteria, instability due to acidic and alkaline environments, and potential safety risks from exogenous additives, failing to achieve comprehensive immune regulation and intestinal barrier repair.
A composition comprising live-bacteria and homologous postbiotic lyophilized powders of Lactobacillus acidophilus, Lactobacillus plantarum, and Bifidobacterium longum, with a specific mass ratio and preparation process ensuring stability and safety, avoiding exogenous additives.
The composition achieves deep synergistic enhancement of strain efficacy, providing immediate and long-term immune regulation, inflammation suppression, and intestinal barrier repair, while ensuring safety and stability.